Michalon et al. (2012) showed that CTEP, a selective mGlu5 inhibitor, was able to correct both the enhanced mGluR-LTD and the cognitive deficits and auditory hyperactivity in the Fragile X mouse model71. This evidence concerns the gene GRM5 and Cognitive impairment.